Le Lézard
Classified in: Health
Subject: SVY

Global self-injections market is expected to grow with a CAGR of 14.80% over the forecast period from 2018-2024


NEW YORK, Feb. 17, 2020 /PRNewswire/ --

The report on the global self-injections market provides qualitative and quantitative analysis for the period from 2016 to 2024.

Read the full report: https://www.reportlinker.com/p05751706/?utm_source=PRN

The report predicts the global self-injections market to grow with a CAGR of 14.80% over the forecast period from 2018-2024. The study on self-injections market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on self-injections market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global self-injections market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global self-injections market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
? Increasing demand for home health care
? Increasing incidents of autoimmune and chronic disease
2) Restraints
? Several side-effects associated with self-injections

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global self-injections market is segmented on the basis of type, applications, usage, and distribution channel.

The Global Self-injections Market by Type
? Wearable Injectors
? Needle-free Injectors
? Pen Injectors
? Auto Injectors

The Global Self-injections Market by Applications
? Respiratory Therapy
? Autoimmune Diseases
? Orphan Diseases
? Hormonal Disorders

The Global Self-injections Market by Usage
? Reusable
? Disposable

The Global Self-injections Market by Distribution Channel
? Online Pharmacies
? Private Clinics
? Hospital Pharmacies

Company Profiles
? Wilhelm Haselmeier GmbH & Co. KG
? Becton, Dickinson and Company
? SHL Group
? Gerresheimer AG
? Owen Mumford Ltd
? Insulet Corporation
? Sensile Medical AG
? Ypsomed AG
? Consort Medical plc
? West Pharmaceutical Services, Inc.

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the self-injections market.
2. Complete coverage of all the segments in the self-injections market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global self-injections market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Read the full report: https://www.reportlinker.com/p05751706/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

23 avr 2024
Astellas Pharma Inc....



News published on and distributed by: